TScan Therapeutics
TCRX
#9301
Rank
โ‚น5.80 B
Marketcap
โ‚น102.50
Share price
-5.51%
Change (1 day)
-83.24%
Change (1 year)

TScan Therapeutics (TCRX) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : โ‚น11.20 Billion

According to TScan Therapeutics's latest financial reports the company's total liabilities are โ‚น11.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

TScan Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น11.16 B10.58%
2023-12-31โ‚น10.09 B22.43%
2022-12-31โ‚น8.24 B305.41%
2021-12-31โ‚น2.03 B-69.83%
2020-12-31โ‚น6.74 B42.15%
2019-12-31โ‚น4.74 B